KRAS and pachyonychia congenita: Furthermore, Liu et al. observed that PC development is aided by the modification of the miR-96-5p/KRAS/MAPK axis, which suggests that the specifically overexpressed has-circ-0006117 may be a potential target for PC therapy [43] (Fig. 1).